课题基金 / 基金详情

Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome

Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
急性肺损伤和急性呼吸窘迫综合征的治疗
批准号:
8602423
负责人:
Rolf D Hubmayr
金额:
$7.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-30 至 2013-07-15

项目摘要

项目成果

Rolf D Hubmayr的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Acute lung injury (ALI) and its more severe form, adult respiratory distress (ARD), is a devastating clinical syndrome of sudden lung inflammation that results in severe edema and hypoxemia and requires care in the intensive care unit. Mortality is between 30-40% in controlled settings. To date, no single drug has proven effective for improving mortality in ALI/ARDS despite many large and small clinical trials. The objective of the Clinical Research Network (ARDSNet) is to develop and conduct clinical research trials to prevent, treat, and improve the outcome of patients with acute lung injury, acute respiratory distress syndrome, and possibly other related critical illnesses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Core
Clinical Core
ARDS - SAILS Protocol
  • 批准号:
    8602426
  • 项目类别:
  • 资助金额:
    $4.56万
  • 财政年份:
    2005
  • 负责人:
    Rolf D Hubmayr
  • 依托单位:
ARDS
  • 批准号:
    7542681
  • 项目类别:
  • 资助金额:
    $29.83万
  • 财政年份:
    2005
  • 负责人:
    Rolf D Hubmayr
  • 依托单位:
    --
海外基金